Evidence map›Paper›PMID 41646979›Full record

ArticleFrontiers in immunology2025

Immunogenicity evaluation of altSonflex1-2-3

Valentina Caradonna, Renzo Alfini, Marika Pinto, Roberta Di Benedetto, Carlo Giannelli, Donata Medaglini, Elena Pettini, Miren Iturriza, Omar Rossi, Francesca Micoli and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Valentina CaradonnaLaboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Renzo AlfiniGlaxoSmithKline (GSK) Vaccines Institute for Global Health (GVGH), Siena, Italy.
Marika PintoGlaxoSmithKline (GSK) Vaccines Institute for Global Health (GVGH), Siena, Italy.
Roberta Di BenedettoGlaxoSmithKline (GSK) Vaccines Institute for Global Health (GVGH), Siena, Italy.
Carlo GiannelliGlaxoSmithKline (GSK) Vaccines Institute for Global Health (GVGH), Siena, Italy.
Donata MedagliniLaboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Elena PettiniLaboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Miren IturrizaGlaxoSmithKline (GSK) Vaccines Institute for Global Health (GVGH), Siena, Italy.
Omar RossiGlaxoSmithKline (GSK) Vaccines Institute for Global Health (GVGH), Siena, Italy.
Francesca MicoliGlaxoSmithKline (GSK) Vaccines Institute for Global Health (GVGH), Siena, Italy.
Francesca ManciniGlaxoSmithKline (GSK) Vaccines Institute for Global Health (GVGH), Siena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dysentery, BacillaryImmunogenicity, VaccineO AntigensShigella flexneriShigella sonneiShigella VaccinesAnimalsAntibodies, BacterialAntigens, BacterialDisease Models, AnimalFemaleHumansImmunoglobulin GMiceRabbitsRatsAntibodies, BacterialAntigens, BacterialImmunoglobulin GO AntigensShigella VaccinesaltSonflex1-2-3animal modelsdose-responseGMMAShigellavaccine

Identifiers

PMID41646979
PMCPMC12868232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.